A new HIV prevention drug will soon be available at a lower cost in more than 100 low-income countries, a move that could give millions access to breakthrough treatment and bring the world closer to ending the HIV/Aids epidemic. The injectable drug, Lenacapavir, is expected to be rolled out as early as the end of this year. While it currently costs around $28,000 (£20,000) per person annually, Wednesday’s announcement promises to slash that price to just $40 - around 0.1% of the original cost. T

##CloseTheGap Condoms are the mainstay of prevention of HIV/AIDS, sexually transmitted diseases, and unwanted pregnancy. | National Department of Health (South Africa)

4 comments | A study released by UNAIDS earlier this year indicates...

5.6K views · 213 reactions | "Every day 300 young people and children lose their lives to AIDS." Over two million young people have HIV/AIDS, with the majority living in Africa. But UNICEF'S head of HIV/Aids, Anurita Bains, warns that a decade of progress on HIV is stagnating  #WorldAIDSDay | BBC News Africa | Facebook